Abstract:The 1921 discovery of insulin was a Big Bang from which a vast and expanding universe of research into insulin action and resistance has issued. In the intervening century, some discoveries have matured, coalescing into solid and fertile ground for clinical application; others remain incompletely investigated and scientifically controversial. Here, we attempt to synthesize this work to guide further mechanistic investigation and to inform the development of novel therapies for type 2 diabetes (T2D). The rational development of such therapies necessitates detailed knowledge of one of the key pathophysiological processes involved in T2D: insulin resistance. Understanding insulin resistance, in turn, requires knowledge of normal insulin action. In this review, both the physiology of insulin action and the pathophysiology of insulin resistance are described, focusing on three key insulin target tissues: skeletal muscle, liver, and white adipose tissue. We aim to develop an integrated physiological perspective, placing the intricate signaling effectors that carry out the cell-autonomous response to insulin in the context of the tissue-specific functions that generate the coordinated organismal response. First, in section II, the effectors and effects of direct, cell-autonomous insulin action in muscle, liver, and white adipose tissue are reviewed, beginning at the insulin receptor and working downstream. Section III considers the critical and underappreciated role of tissue crosstalk in whole body insulin action, especially the essential interaction between adipose lipolysis and hepatic gluconeogenesis. The pathophysiology of insulin resistance is then described in section IV. Special attention is given to which signaling pathways and functions become insulin resistant in the setting of chronic overnutrition, and an alternative explanation for the phenomenon of ‟selective hepatic insulin resistanceˮ is presented. Sections V, VI, and VII critically examine the evidence for and against several putative mediators of insulin resistance. Section V reviews work linking the bioactive lipids diacylglycerol, ceramide, and acylcarnitine to insulin resistance; section VI considers the impact of nutrient stresses in the endoplasmic reticulum and mitochondria on insulin resistance; and section VII discusses non-cell autonomous factors proposed to induce insulin resistance, including inflammatory mediators, branched-chain amino acids, adipokines, and hepatokines. Finally, in section VIII, we propose an integrated model of insulin resistance that links these mediators to final common pathways of metabolite-driven gluconeogenesis and ectopic lipid accumulation.

Mapping the landscape of research on insulin resistance: a visualization analysis of randomized clinical trials

Research Progress on the Relationship between High-fat Diet, Intestinal Flora, Bile Acid Metabolism and Insulin Resistance

Global research trends on the links between insulin resistance and obesity: a visualization analysis

The undervalued league of insulin resistance testing: uncovering their importance

Trends in insulin resistance: insights into mechanisms and therapeutic strategy

Gut microbiota in insulin resistance: a bibliometric analysis

Recent Advances in Our Understanding of Insulin Action and Insulin Resistance

A Glimpse into Milestones of Insulin Resistance and an Updated Review of Its Management

A Bibliometric and Knowledge‐Map Analysis of Macrophage Polarization in Insulin Resistance From 1999 to 2023

Mapping Research Trends of Insulin Resistance in Polycystic Ovary Syndrome from 2017 to 2021: A Bibliometric Analysis

The aetiology and molecular landscape of insulin resistance

Study on insulin resistance and ischemic cerebrovascular disease: A bibliometric analysis via CiteSpace

The crucial role and mechanism of insulin resistance in metabolic disease

Insulin Signal Transduction Perturbations in Insulin Resistance

Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?

Mechanisms of Insulin Action and Insulin Resistance

Insulin resistance: Review of the underlying molecular mechanisms

Diverse Strategies for Modulating Insulin Resistance: Causal or Consequential Inference on Metabolic Parameters in Treatment-Naïve Subjects with Type 2 Diabetes

Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies

Insulin resistance and insulin sensitizing agents

Insulin Resistance